Duramed Cenestin And Pfizer Aricept In Pilot Study For Early Alzheimer's

12 Mar 2001

• By The Pink Sheet

Duramed is planning clinical studies of its synthetic conjugated estrogen Cenestin in combination with Pfizer/Eisai's Aricept for treatment of early Alzheimer's disease, the company said during a Feb. 28 conference call.

Duramed Cenestin And Pfizer Aricept In Pilot Study For Early Alzheimer's

More from Archive

More from Pink Sheet